North America Probiotics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The north america probiotics market was valued at USD 7.31 billion in 2025, and is estimated to grow from USD 7.84 billion in 2026 to reach USD 11.10 billion by 2031, growing at a CAGR of 7.20% during the forecast period. This report is Segmented by Product Type (Probiotic Foods, Probiotic Drinks and Dietary Supplements), Distribution Channel (Supermarkets/Hypermarkets, Pharmacies/Health Stores, Convenience Stores, Online Retail Stores and Other Distribution Channels), and Geography (United States, Canada, Mexico and Rest of North America). The Market Forecasts are Provided in Terms of Value (USD).

North America Probiotics Market Trends and Insights

Growing focus on digestive wellness demand

Digestive health has emerged as a high-growth opportunity, now ranking as the fourth most sought-after health benefit among U.S. consumers, with 36% actively seeking gut-health solutions across foods, beverages, and supplements. Younger cohorts, particularly Gen Z and Millennials, are accelerating category momentum by linking digestive health with adjacent benefits such as energy, weight management, and overall performance. This enables brands to expand beyond traditional supplements into probiotic-enhanced snacks, beverages, and meal replacements with broader lifestyle positioning. The North American market has witnessed increased investment in research and development by major manufacturers to develop innovative probiotic formulations targeting specific health conditions, as exemplified by Danone's 2024 establishment of the Activia Gut Health Board, which aims to provide expert guidance and support for improving digestive health. From a regulatory perspective, the U.S. environment is supportive. The FDA’s structure/function claim framework permits digestive health messaging without premarket approval, lowering regulatory hurdles and accelerating SKU development and portfolio expansion. Together, these factors make digestive health a scalable platform for growth, differentiation, and cross-category innovation.

Dairy-free and plant probiotics expand consumers

Plant-based probiotic innovations are expanding market reach by addressing previously inaccessible consumer segments. These products address multiple consumer needs simultaneously, including lactose intolerance accommodation, environmental sustainability concerns, and protein diversification requirements. Additionally, the growing consumer awareness of gut health benefits, coupled with the rising adoption of plant-based diets and product launches such as Danone Canada's Silk, which in February 2024 launched a plant-based yogurt, has created a favorable environment for the expansion of plant-based probiotic products across the region. Plant-based probiotic products are able to sustain premium pricing by targeting higher-income consumers who prioritize perceived health value over price. IFIC data indicate that in households earning over USD 100,000 annually, healthfulness is a stronger purchase driver than cost, supporting margin expansion and premium portfolio strategies.

Growing Consumer Preference for Natural and Fresh Foods as Substitutes

The North American probiotics market faces a strategic tension: while 36% of consumers actively seek digestive health benefits, 79% are concerned about food processing, and 63% sometimes avoid processed foods as per International Food Information Council Food & Health Survey, 2024. This challenge is particularly pronounced in the dietary supplements segment, where capsules and tablets carry a pharmaceutical perception that conflicts with the “food-as-medicine” ethos. Consumers increasingly prefer minimally processed, whole-food sources such as kefir, sauerkraut, and kimchi, while USDA guidance restricts “natural” claims to products without synthetic additives, forcing brands to choose between clinical (CFU and strain-specific) and natural positioning. Shelf-stable formats face perception and processing challenges, whereas fresh refrigerated products benefit from a health halo but are limited by distribution and spoilage risk.

Other drivers and restraints analyzed in the detailed report include:

• E-commerce growth improves probiotic accessibility
• Increasing interest in functional foods and fermented products is boosting overall probiotic consumption
• Lack of Standardized Labeling Affects Transparency and Trust

Segment Analysis

The North American probiotics market is led by probiotic foods, which accounted for 61.08% of market share in 2025, driven by the widespread presence of yogurt in refrigerated dairy aisles and the clinical validation of infant formulas for C-section and preterm infants. Yogurt remains the category workhorse, with advanced culture technologies enabling manufacturers to reduce dairy solids while delivering premium texture and digestive-health benefits through clinically studied strains. Infant formula is experiencing a post-pandemic resurgence, with formulations targeting microbiome diversity in C-section deliveries capturing a significant share of the premium segment. Beyond formula, baby food is also expanding as parents increasingly prioritize early gut-health interventions, although regulatory caution around infant dosing continues to constrain innovation. Probiotic drinks are the fastest-growing segment, with a projected CAGR of 9.54% through 2031, driven by demand for convenient, on-the-go formats and innovation in dairy-free options such as kombucha and fermented teas.

In parallel, dairy-based formats, including kefir and drinkable yogurts, are expanding beyond digestive health through protein fortification, enabling positioning around satiety, recovery, and daily performance and increasing consumption occasions. The dietary supplements segment, including capsules, tablets, powders, and gummies, exhibits bifurcated demand. Gummies are experiencing rapid growth, driven by convenience and consumer-friendly taste, while capsules maintain clinical credibility for precise therapeutic dosing. Premium multi-strain formulations can command high price points, reflecting consumer willingness to pay for perceived efficacy, quality, and trusted strains, positioning this segment as a high-margin opportunity within the broader probiotics market.

Complete Report Scope:

• By Product Type
  • Probiotic Foods
    • Yogurt
    • Bakery/Breakfast Cereals
    • Baby Food and Infant Formula
    • Other Probiotic Foods
  • Probiotic Drinks
    • Dairy-based Drinks
    • Fruit/Plant-based Drinks
    • Others
  • Dietary Supplements
    • Capsules
    • Tablets
    • Powders
    • Gummies
    • Others
• By Distribution Channel
  • Supermarkets/Hypermarkets
  • Pharmacies/Health Stores
  • Convenience Stores
  • Online Retail Stores
  • Other Distribution Channels
• By Geography
  • United States
  • Canada
  • Mexico
  • Rest of North America

List of Companies Covered in this Report:

• Danone
• Nestlé S.A.
• PepsiCo Inc
• BioGaia AB
• Chobani LLC
• Amway Corporation
• Lifeway Foods Inc
• Lallemand Inc
• Reckitt Benckiser
• Yakult Honsha Co Ltd
• Chr. Hansen Holding A/S
• du Pont de Nemours and Company
• Kerry Group plc
• Archer Daniels Midland Company
• General Mills Inc
• Culturelle
• Garden of Life LLC
• Otsuka Pharmaceutical Co., Ltd
• Probi AB
• Green Valley Creamery

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support